DCF — BAPTIST HEALTH CORBIN
Enterprise Value: $-16.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-16.7M
Enterprise Value
$-12.6M
PV of Cash Flows
$-4.0M
PV of Terminal Value
$-6.5M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $293.9M | $5.5M | 2.0% | $-6.9M | $-6.3M |
| Year 2 | $302.8M | $8.7M | 3.0% | $-4.4M | $-3.6M |
| Year 3 | $311.8M | $12.1M | 4.0% | $-2.2M | $-1.7M |
| Year 4 | $321.2M | $14.0M | 4.0% | $-1.1M | $-0.7M |
| Year 5 | $330.8M | $15.3M | 5.0% | $-0.5M | $-0.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-16.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$285.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.01369048321347231
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5